Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Impact of Mogamulizumab-Containing Chemotherapy on HBV Reactivation in Patients with T-Cell Lymphoma: A Multicenter Retrospective Observational Study (PROACTIVE-MOGA)

Blood (2023) 142 (Supplement 1): 6192.

https://doi.org/10.1182/blood-2023-185878

Published: 2023

Journal Articles

iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study

Blood (2022) 140 (22): 2398–2402.

https://doi.org/10.1182/blood.2022017296

Published: 2022

Includes: Supplemental data

Journal Articles

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Blood (2010) 116 (21): 3551.

https://doi.org/10.1182/blood.V116.21.3551.3551

Published: 2010

Journal Articles

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

Blood (2010) 116 (8): 1211–1219.

https://doi.org/10.1182/blood-2009-12-257410

Published: 2010

Includes: Supplemental data

Journal Articles

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

Takahiko Nakane, MD, PhD, Hirohisa Nakamae, MD, PhD, Hideo Koh, MD, Mika Nakamae, MD, PhD, Yoshiki Hayashi, MD, Mitsutaka Nishimoto, MD, Takuro Yoshimura, MD, Eri Inoue, MD, Atsushi Inoue, MD, Ran Aimoto, MD, Mizuki Aimoto, MD, Yoshiki Terada, MD, PhD, Ki-Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Masayuki Hino, MD, PhD

Blood (2009) 114 (22): 4347.

https://doi.org/10.1182/blood.V114.22.4347.4347

Published: 2009

Journal Articles

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, MD, PhD, Ran Moriguchi, MD, Hiroshi Kanashima, MD, PhD, Erina Sakamoto, MD, PhD, Dai Momose, MD, Mizuki Aimoto, MD, Shuichirou Okamoto, MD, Eri Wada, MD, Hideo Koh, MD, Takahiko Nakane, MD, Yasunobu Takeoka, MD, Ki- Ryang Koh, MD, PhD, Takahisa Yamane, MD, PhD, Yoshitaka Nakao, MD, PhD, Kensuke Ohta, MD, PhD, Atsuko Mugitani, MD, PhD, Hirofumi Teshima, MD, PhD, Masayuki Hino, MD, PhD

Blood (2008) 112 (11): 4931.

https://doi.org/10.1182/blood.V112.11.4931.4931

Published: 2008

Journal Articles

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Hongzhang Li, M.D., Hideo Koh, M.D., Takahiko Nakane, M.D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph.D., Kiyoyuki Hagihara, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Mika Nakamae, M.D., Ph.D., Yoshiki Terada, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 1971.

https://doi.org/10.1182/blood.V110.11.1971.1971

Published: 2007

Journal Articles

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Yoshiki Terada, MD, PhD, Hirohisa Nakamae, M.D., Ph.D., Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Ran Moriguchi, M.D., Mizuki Aimoto, M.D., Yuki Akazawa, M.D., Eri Wada, M.D., Hiroshi Kanashima, M.D., Ph.D., Erina Sakamoto, M.D., Ph.D., Ki-Ryang Koh, M.D., Ph.D., Takahisa Yamane, M.D., Ph.D., Kensuke Ohta, M.D., Ph.D., Yoshitaka Nakao, M.D., Ph.D., Hirofumi Teshima, M.D., Ph.D., Masayuki Hino, M.D., Ph.D.

Blood (2007) 110 (11): 4456.

https://doi.org/10.1182/blood.V110.11.4456.4456

Published: 2007

Journal Articles

Non-TBI, Non-ATG Containing Fludarabine-Based Regimen for Unrelated Allogeneic Reduced Intensity Transplantation.

Hirohisa Nakamae, MD, PhD, Takahiko Nakane, M.D., Hideo Koh, M.D., Yasunobu Takaoka, M.D.,Ph.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.

Blood (2006) 108 (11): 5382.

https://doi.org/10.1182/blood.V108.11.5382.5382

Published: 2006

Journal Articles

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Takahiko Nakane, MD, Hirohisa Nakamae, M.D.,Ph.D., Hiroshi Kamoi, M.D.,Ph.D., Hideo Koh, M.D., Yasunobu Takeoka, M.D., Erina Sakamoto, M.D.,Ph.D., Hiroshi Kanashima, M.D.,Ph.D., Hiroyoshi Ichihara, M.D., Mika Nakamae, M.D.,Ph.D., Ki-Ryang Koh, M.D.,Ph.D., Takahisa Yamane, M.D.,Ph.D., Masayuki Hino, M.D.,Ph.D.

Blood (2006) 108 (11): 2915.

https://doi.org/10.1182/blood.V108.11.2915.2915

Published: 2006

Journal Articles

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Ki-Ryang Koh, MD, PhD, Hirohisa Nakamae, M.D., Ph. D., Kensuke Ohta, M.D., Ph. D., Hideo Koh, M.D., Takahiko Nakane, M.D., Mika Nakamae, M.D., Ph. D., Hiroshi Kanashima, M.D., Ph. D., Kiyoyuki Hagihara, M.D., Ph. D., Erina Sakamoto, M.D., Ph. D., Yoshiki Terada, M.D., Ph. D., Yasunobu Takeoka, M.D., Asao Hirose, M.D., Ph. D., Takahisa Yamane, M.D., Ph. D., Masayuki Hino, M.D., Ph.D

Blood (2006) 108 (11): 2885.

https://doi.org/10.1182/blood.V108.11.2885.2885

Published: 2006

Journal Articles

Chronic Myeloid Leukemia in Two Patients with Gastrointestinal Stromal Tumor.

Erina Sakamoto, MD, Hirohisa Nakamae, MD, Ki Ryang Koh, MD, Takahisa Yamane, MD, Masayuki Hino, MD

Blood (2006) 108 (11): 4767.

https://doi.org/10.1182/blood.V108.11.4767.4767

Published: 2006

Journal Articles

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Hirohisa Nakamae, MD, PhD, Takahisa Yamane, MD, PhD, Hagihara Kiyoyuki, MD., PhD., Yasunobu Takeoka, MD., Erina Sakamoto, MD., PhD., Takahiko Nakane, MD., Mika Nakamae, MD., PhD., Ki-Ryang Koh, MD., PhD., Kensuke Ohta, MD., PhD., Masayuki Hino, MD., PhD.

Blood (2005) 106 (11): 1775.

https://doi.org/10.1182/blood.V106.11.1775.1775

Published: 2005

Journal Articles

Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis

Ki-Ryang Koh, Martin Janz, Markus Y. Mapara, Britt Lemke, David Stirling, Bernd Dörken, Martin Zenke, Suzanne Lentzsch

Blood (2005) 105 (10): 3833–3840.

https://doi.org/10.1182/blood-2004-03-0828

Published: 2005

Journal Articles

Stimulation of the Supportive Function of Marrow Stromal Cells by Anticancer Agents: Critical Role of Marrow Macrophages.

Kensuke Ohta, M.D., Hirohisa Nakamae, M.D., Ki-Ryang Koh, M.D., Kiyotaka Nakaie, Hong-Zhang Li, Takahisa Yamane, M.D., Takayuki Takubo, M.D., Masayuki Hino, M.D.

Blood (2004) 104 (11): 4252.

https://doi.org/10.1182/blood.V104.11.4252.4252

Published: 2004

NARROW

Impact of Mogamulizumab-Containing Chemotherapy on HBV Reactivation in Patients with T-Cell Lymphoma: A Multicenter Retrospective Observational Study (PROACTIVE-MOGA)

iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study

Factors That Contribute to Long-Term Survival In Patients with Leukemia Not In Remission at Allogeneic Hematopoietic Cell Transplantation

Human T-cell leukemia virus type I (HTLV-1) proviral load and disease progression in asymptomatic HTLV-1 carriers: a nationwide prospective study in Japan

Feasibility of Cyclosporine and Short-Term Methotrexate for Graft-Vs.-Host disease Prophylaxis in T-Cell-Replete, Reduced-Intensity Allogeneic Bone Marrow Transplantation From Unrelated Donors.

The Impact of Relative Dose Intensity of Rituximab-CHOP on Survival in Diffuse Large B-Cell Lymphoma Patients

Possible Involvement of γδ-T Cells in the Development of Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

The Impact of Relative Dose Intensity (RDI) of CHOP on Outcome of Diffuse Large B-Cell Lymphoma: Results of a Single Center Study.

Non-TBI, Non-ATG Containing Fludarabine-Based Regimen for Unrelated Allogeneic Reduced Intensity Transplantation.

Decreased Serum Levels of Surfactant Protein D (SP-D) Prior Transplant Is Associated with the Development of Bronchiolitis Obliterans (BO) and Idiopathic Pneumonia Syndrome (IPS) Following Allogeneic Hematopoietic Stem Cell Transplantation.

Preferential Th2 Polarization at the Onset of Thrombotic Microangiopathy (TMA): Immunological Comparison of TMA Versus Acute GVHD in Terms of Peripheral T Cell Subsets, Dendritic Cell Subsets and Cytokine Profiles.

Chronic Myeloid Leukemia in Two Patients with Gastrointestinal Stromal Tumor.

Risk Factor Analysis for Thrombotic Microangiopathy after Reduced Intensity or Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation.

Immunomodulatory derivative of thalidomide (IMiD CC-4047) induces a shift in lineage commitment by suppressing erythropoiesis and promoting myelopoiesis

Stimulation of the Supportive Function of Marrow Stromal Cells by Anticancer Agents: Critical Role of Marrow Macrophages.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only